612 filings
Page 2 of 31
3/A
Aleta Shiff
12 Sep 23
NeuBase Therapeutics / Aleta Shiff ownership change
5:20pm
4
Symetryx Corp
11 Sep 23
Change in insider ownership
5:08pm
4
Symetryx Corp
7 Sep 23
Change in insider ownership
5:19pm
3
Symetryx Corp
1 Sep 23
Initial statement of insider ownership
2:51pm
SC 13D
NBSE
NeuBase Therapeutics Inc
31 Aug 23
NeuBase Therapeutics / Symetryx ownership change
11:50am
10-Q
2023 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 Aug 23
4:11pm
ARS
2022 FY
NBSE
NeuBase Therapeutics Inc
11 Aug 23
Annual report to shareholders
6:20am
DEFA14A
NBSE
NeuBase Therapeutics Inc
11 Aug 23
Additional proxy soliciting materials
6:18am
DEF 14A
NBSE
NeuBase Therapeutics Inc
Definitive proxy
11 Aug 23
6:15am
EFFECT
NBSE
NeuBase Therapeutics Inc
11 Aug 23
Notice of effectiveness
12:15am
424B3
NBSE
NeuBase Therapeutics Inc
10 Aug 23
Prospectus supplement
5:13pm
CORRESP
NBSE
NeuBase Therapeutics Inc
7 Aug 23
Correspondence with SEC
12:00am
4
Stephan Dietrich A
4 Aug 23
NeuBase Therapeutics / Dietrich A Stephan ownership change
4:39pm
8-K
NBSE
NeuBase Therapeutics Inc
3 Aug 23
NeuBase Therapeutics to Explore Strategic Alternatives
7:05am
UPLOAD
NBSE
NeuBase Therapeutics Inc
3 Aug 23
Letter from SEC
12:00am
PRE 14A
NBSE
NeuBase Therapeutics Inc
Preliminary proxy
1 Aug 23
4:45pm
8-K
NBSE
NeuBase Therapeutics Inc
31 Jul 23
Departure of Directors or Certain Officers
4:10pm
S-1
NBSE
NeuBase Therapeutics Inc
28 Jul 23
IPO registration
6:03am
D
NBSE
NeuBase Therapeutics Inc
7 Jul 23
Exempt offering of security
4:11pm
8-K
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm